This compound is a pharmaceutical intermediate used in the synthesis of other chemical entities. Its structure includes aromatic rings, an alcohol group, and a carbamate moiety, indicating a role in complex organic synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 191226-98-9
Tert-Butyl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate
api impurity reference standard
Tert-Butyl ((2R,3R)-4-(4-acetamido-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate
pharmaceutical intermediate
Ezetimibe Ketone
pharmaceutical intermediate
Fmoc-Tyr(HPO3Bzl)-OH
Phosphotyrosine building block for peptide synthesis
1,2,3,4-Tetrahydro-1-naphthoic acid
Pharmaceutical intermediate
Methyl 3,4,5-trimethoxybenzoate
Pharmaceutical intermediate
N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide
n.a
N-((2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl)-N-(2-methylpropyl)-4-aminobenzenesulfonamide
Darunavir metabolite and intermediate
tert-butyl N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-(4-nitrophenyl)sulfonylamino]-1-phenylbutan-2-yl]carbamate
CQGKCZKCWMWXQP-XZOQPEGZSA-N
CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C)O)S(=O)(=O)C2=CC=C(C=C2)[N+](=O)[O-]
—